Back to search

Interferon-γ expression is an independent prognostic factor in ovarian cancer

Data up to Jan 2025

Published2004
Citations83
References29

Total Citations Per Year

Abstract

References (29)

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1987 • 64,270 citations

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

1987 • 45,673 citations

Cancer Statistics, 2004

2004 • 4,026 citations

Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

2003 • 3,194 citations

Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice

1998 • 1,400 citations

SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity

2001 • 695 citations

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma.

1996 • 529 citations

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

1995 • 446 citations

Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB

2001 • 313 citations

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

2000 • 235 citations

The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein

1996 • 159 citations

Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.

1996 • 158 citations

Epigenetic silencing of multiple interferon pathway genes after cellular immortalization

2003 • 143 citations

Review: IRF-1 as a Negative Regulator of Cell Proliferation

2002 • 115 citations

Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.

2002 • 109 citations

Phenotypic and Functional Analysis of Tumor-Infiltrating Lymphocytes Compared with Tumor-Associated Lymphocytes from Ascitic Fluid and Peripheral Blood Lymphocytes in Patients with Advanced Ovarian Cancer

2001 • 77 citations

Analyses ofMYC,ERBB2, andCCND1Genes in Benign and Malignant Thyroid Follicular Cell Tumors by Real-Time Polymerase Chain Reaction

2001 • 61 citations

IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo

2003 • 60 citations

Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells.

1990 • 56 citations

Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA

1999 • 53 citations

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNγ-induced cell death in human ovarian carcinoma cells

2002 • 51 citations

Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.

1993 • 43 citations

Effects of biological response modifiers on ovarian carcinoma cell lines.

1989 • 38 citations

Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer.

2000 • 38 citations

Clonal Expansion of T Cells That Are Specific for Autologous Ovarian Tumor among Tumor-Infiltrating T Cells in Humans1

1999 • 37 citations

Nitric Oxide-Dependent Apoptosis in Ovarian Carcinoma Cell Lines

2001 • 35 citations

Effector pathways regulating T cell activation

1998 • 33 citations

A Positive Regulatory Role for Suppressor of Cytokine Signaling 1 in IFN-γ-Induced MHC Class II Expression in Fibroblasts

2002 • 28 citations

Die intraperitoneale Instillation von Interferon-gamma zur Behandlung des refraktären Ovarialkarzinoms

1989 • 11 citations

Cited By (0)

No citing papers found in database

Interferon-γ expression is an independent prognostic factor in ovarian cancer (2004) – American Journal of Obstetrics and Gynecology | Metascience Observatory Explorer